

<h3>Bibliografía</h3>

    <ol>
        <li>Fisher MJ. Brain Regulation of Thrombosis and Hemostasis. From Theory to Practice. Stroke 2013;44(11):3275-85.</li>
        <li>Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guideline from the AHA/ASA: Guidelines for the Early Management of Patients with Acute Ischemic Stroke. Stroke 2013;44:870-947.</li>
        <li>Oliveira Filho J, Mullen MT. Antithrombotic treatment of acute ischemic stroke and transient ischemic attack. Up to date: Aug 2017.</li>
        <li>Alonso de Leciñana M, Egido JA, Casado I, Ribó M, Dávalos A, Masjuan J, et al; SEN. Guidelines for the treatment of acute ischaemic stroke. Neurología 2014;29(2):102-22.</li>
        <li>Trombolisis en ictus isquémico. Sociedad Valenciana de Neurología. Disponible en: <a href="http://www.svneurologia.org/fc/TROMBOLISIS07.pdf" target="_blank">http://www.svneurologia.org/fc/TROMBOLISIS07.pdf</a></li>
        <li>Cuker A. Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication. J Thromb Thrombolysis 2016;41(2):241-7.</li>
        <li>Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke 2015;46:3020-35.</li>
        <li>Kaul M, Erkan D, Lisa Sammaritano L, Lockshin MD. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 2007;66(7):927-30.</li>
        <li>KL Furie, Kasner SE, Adams RJ, Ruth GW, Bush L, Fagan SC, et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline From the AHA/ASA. Stroke 2011;42:227-76.</li>
        <li>Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the AHA/ASA. Stroke 2014;45(7):2160-236.</li>
        <li>Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 2008;39(11):2993-6.</li>
        <li>Gulati D, Dua D, Torbey MT. Hemostasis in Intracranial Hemorrhage. Front Neurol 2017;15(8):1-8.</li>
        <li>Béjot Y, Cordonnier C, Durier J, Aboa-Eboulé C, Rouaud O, Giroud M. Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study. Brain 2013;136(Pt 2): 658-64.</li>
        <li>Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, et al; British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol 2011;154(3):311-24.</li>
        <li>Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis 2016;41(1):187-205.</li>
        <li>Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol 2012;110(3):453-60.</li>
        <li>Dolgin E. Antidotes edge closer to reversing effects of new blood thinners. Nat Med 2013;19:251.</li>
        <li>Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Althaus K, et al. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany national case collection. Int J Stroke 2017;12(4):383-91.</li>
        <li>Kim JH, Baek CH, Min JY, Kim JS, Kim SB, Kim H. Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures. Ann Hematol 2015;94(9):1457-61.</li>
        <li>Coutinho JM. Cerebral venous thrombosis. J Thromb Haemost 2015;13(Suppl. 1):S238-S44</li>
    </ol>